©The Author(s) 2017.
World J Gastroenterol. Nov 21, 2017; 23(43): 7693-7704
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7693
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7693
Table 1 Levels of chitinase 3-like 1 and clinical and laboratory characteristics of 150 esophageal squamous cell carcinoma patients
| Characteristics | No. of patients | Levels of CHI3L1 | ||
| Low | High | P value | ||
| All | 150 | 97 | 53 | |
| Age | 0.009 | |||
| Median | 60 | |||
| Range | 30-96 | |||
| < 60 | 81 | 60 | 21 | |
| ≥ 60 | 69 | 37 | 32 | |
| Sex | 0.713 | |||
| Male | 113 | 74 | 39 | |
| Female | 37 | 23 | 14 | |
| Smoking status | 0.514 | |||
| Smoker | 99 | 66 | 33 | |
| Non-smoker | 49 | 30 | 19 | |
| Alcohol intake | 0.984 | |||
| Yes | 56 | 36 | 20 | |
| No | 90 | 58 | 32 | |
| Grade | 0.736 | |||
| Grade 1 | 24 | 16 | 8 | |
| Grade 2 | 57 | 36 | 21 | |
| Grade 3 | 41 | 29 | 12 | |
| T status | 0.886 | |||
| pT 1/2 | 31 | 21 | 10 | |
| pT 3/4 | 113 | 75 | 38 | |
| N status | 0.154 | |||
| pN 0 | 63 | 46 | 17 | |
| pN 1/2/3 | 81 | 50 | 31 | |
| M status | 0.156 | |||
| pM 0 | 112 | 78 | 34 | |
| pM 1 | 32 | 18 | 14 | |
| Stage | 0.712 | |||
| I–II | 51 | 35 | 16 | |
| III-IV | 93 | 61 | 32 | |
| SCCA | 0.539 | |||
| ≤ 1.5 | 101 | 67 | 34 | |
| > 1.5 | 49 | 30 | 19 | |
| CEA | 0.389 | |||
| ≤ 5.0 | 132 | 87 | 45 | |
| > 5.0 | 18 | 10 | 8 | |
| Treatment | 0.138 | |||
| Surgery | 73 | 49 | 24 | |
| Chemoradiotherapy | 57 | 37 | 20 | |
| Chemotherapy | 11 | 4 | 7 | |
- Citation: Xing S, Zheng X, Zeng T, Zeng MS, Zhong Q, Cao YS, Pan KL, Wei C, Hou F, Liu WL. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World J Gastroenterol 2017; 23(43): 7693-7704
- URL: https://www.wjgnet.com/1007-9327/full/v23/i43/7693.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i43.7693